Continuum Advisory »

Regulus Therapeutics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $450 300 1.50

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Vanguard Total Stock Market Etf Etf (VTI)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Nvidia Corporation Stock (NVDA)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)

View all positions for Continuum Advisory

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics